Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.

Ortak H, Söğüt E, Ateş O, Erkorkmaz U, Benli I, Akbas A, Demir S, Ozyurt H.

Mol Vis. 2013;19:486-xxx.

2.

Association of paraoxonase 1 L55M and Q192R single-nucleotide polymorphisms with age-related macular degeneration.

Söğüt E, Ortak H, Aydoğan L, Benlı I.

Retina. 2013 Oct;33(9):1836-42. doi: 10.1097/IAE.0b013e318287da59.

PMID:
23538572
3.

Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.

Yaghmaei M, Hashemi M, Azarian A, Moazeni-Roodi A, Mokhtari M, Naghavai A, Salimi S, Mohammadi M, Taheri M, Ghavami S.

Arch Med Res. 2011 May;42(4):324-8. doi: 10.1016/j.arcmed.2011.06.006.

PMID:
21820612
4.

Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.

Ortak H, Demir S, Ateş O, Söğüt E, Alim S, Benli I.

Exp Eye Res. 2013 Aug;113:151-5. doi: 10.1016/j.exer.2013.06.009.

PMID:
23791966
5.

The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.

Hassan MA, Al-Attas OS, Hussain T, Al-Daghri NM, Alokail MS, Mohammed AK, Vinodson B.

Mol Cell Biochem. 2013 Aug;380(1-2):121-8. doi: 10.1007/s11010-013-1665-z.

PMID:
23625196
6.

Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.

Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS.

Arch Med Res. 2007 May;38(4):403-10.

PMID:
17416287
7.

Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.

Rajković MG, Barišić K, Juretić D, Grubišić TŽ, Flegar-Meštrić Z, Rumora L.

Clin Biochem. 2011 Aug;44(12):964-8. doi: 10.1016/j.clinbiochem.2011.05.012.

PMID:
21620813
8.

GENETIC ASSOCIATION BETWEEN ARTERIAL STIFFNESS-RELATED GENE POLYMORPHISMS IN BRVO AND CRVO PATIENTS IN A TURKISH POPULATION.

Demir S, Ortak H, Benli İ, Alim S, Bütün İ, Güneş A, Ateş Ö.

Retina. 2015 Oct;35(10):2043-51. doi: 10.1097/IAE.0000000000000580.

PMID:
25932559
9.

Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.

Veiga L, Silva-Nunes J, Melão A, Oliveira A, Duarte L, Brito M.

Eur J Endocrinol. 2011 Feb;164(2):213-8. doi: 10.1530/EJE-10-0825.

10.

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.

Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD.

Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011.

PMID:
21803130
11.

Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey.

Eren Z, Kantarci G, Biyikli N, Arikan H, Tuglular S, Ergen A, Isbir T, Akoglu E.

Iran J Kidney Dis. 2012 May;6(3):181-5.

12.

Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.

Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.

J Nephrol. 2006 Nov-Dec;19(6):732-8.

PMID:
17173245
13.

Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.

Haj Mouhamed D, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF.

Environ Health Prev Med. 2012 Jul;17(4):316-21. doi: 10.1007/s12199-011-0256-4.

14.

Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.

Stevens VL, Rodriguez C, Pavluck AL, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1226-8.

15.

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

Hussein YM, Gharib AF, Etewa RL, ElSawy WH.

Mol Cell Biochem. 2011 May;351(1-2):117-23. doi: 10.1007/s11010-011-0718-4.

PMID:
21229382
16.

The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.

Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.

Eye (Lond). 2003 Aug;17(6):772-7.

PMID:
12928694
17.

Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.

Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D.

Thromb Res. 2003 Apr 15;110(1):7-12.

PMID:
12877902
18.

PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population.

Arca M, Ombres D, Montali A, Campagna F, Mangieri E, Tanzilli G, Campa PP, Ricci G, Verna R, Pannitteri G.

Eur J Clin Invest. 2002 Jan;32(1):9-15.

PMID:
11851721
19.

Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.

Ortak H, Söğüt E, Demir H, Ardagil A, Benli I, Sahin S.

Clin Exp Ophthalmol. 2012 Sep-Oct;40(7):743-8. doi: 10.1111/j.1442-9071.2012.02780.x.

PMID:
22394334
20.

Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.

Wei GZ, Zhu MY, Wang F, Zhao YG, Li SS, Liu TY, Luo Y, Tang WR.

Z Gerontol Geriatr. 2016 Jan;49(1):24-31. doi: 10.1007/s00391-015-0892-1. Review.

PMID:
25962362
Items per page

Supplemental Content

Support Center